Acute Oral Administration of Single‐Walled Carbon Nanotubes Increases Intestinal Permeability and Inflammatory Responses: Association with the Changes in Gut Microbiota in Mice

With the increasing production and widespread potential applications of single-walled carbon nanotubes (SWCNTs), the possible impacts of oral administration of SWCNTs on gastrointestinal tract at currently occupational exposure limits and potential biomedical applications should be concerned. To address the concerns, mice are orally administrated of SWCNTs at doses of 0.05, 0.5, and 2.5 mg kg-1 body weight per day for 7 d. The investigation shows that SWCNT treatment had promoted intestinal injuries at the acute dose of 2.5 mg kg-1 per day, including increase of histological lesion scores, intestinal permeability, and proinflammatory cytokine (IL-1β, IL-6, and TNF-α) secretion. Analysis of gut microbiota composition using 16S rRNA gene sequencing approach reveals that acute oral administration of SWCNTs induces significant shifts of the predominant microbe phyla from Firmicutes to Bacteroidetes and increases abundance of proinflammatory bacteria Alitipes_uncultured_bacterium and Lachnospiraceae bacterium A4. These notable findings suggest that SWCNT-induced intestinal injury is linked to SWCNT interaction with intestinal tract and gut bacteria and the consequent triggering of "metabolic inflammation" responses. Furthermore, the study has shown that oral administration of carbon nanomaterials, including SWCNTs, multiwalled CNTs, and graphene oxide, can lead to different inflammatory responses and specific alteration in gut microbiota in mice.

[1]  Siqi Huang,et al.  Association of gut microbiota composition and function with a senescence-accelerated mouse model of Alzheimer’s Disease using 16S rRNA gene and metagenomic sequencing analysis , 2018, Aging.

[2]  Jürgen Seitz,et al.  Efficient Elimination of Inhaled Nanoparticles from the Alveolar Region: Evidence for Interstitial Uptake and Subsequent Reentrainment onto Airways Epithelium , 2007, Environmental health perspectives.

[3]  M. Rescigno,et al.  Review the Gut Immune Barrier and the Blood-brain Barrier: Are They so Different? , 2022 .

[4]  N. Zmora,et al.  The microbiome and innate immunity , 2016, Nature.

[5]  P. Hemarajata,et al.  The human gut microbiome and body metabolism: implications for obesity and diabetes. , 2013, Clinical chemistry.

[6]  Kecheng Zhang,et al.  Rhein inhibits lipopolysaccharide-induced intestinal injury during sepsis by blocking the toll-like receptor 4 nuclear factor-κB pathway. , 2015, Molecular medicine reports.

[7]  Artificial sweeteners induce glucose intolerance by altering the gut microbiota , 2014, Nature.

[8]  W G Kreyling,et al.  Long-Term Clearance Kinetics of Inhaled Ultrafine Insoluble Iridium Particles from the Rat Lung, Including Transient Translocation into Secondary Organs , 2004, Inhalation toxicology.

[9]  E. Zoetendal,et al.  Human intestinal microbiota composition is associated with local and systemic inflammation in obesity , 2013, Obesity.

[10]  V. Sperandio,et al.  Interactions between the microbiota and pathogenic bacteria in the gut , 2016, Nature.

[11]  Z. Chai,et al.  Coculture with Low-Dose SWCNT Attenuates Bacterial Invasion and Inflammation in Human Enterocyte-like Caco-2 Cells. , 2015, Small.

[12]  D. Lúdvíksdóttir,et al.  Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma. BHR Group. , 2000, American journal of respiratory and critical care medicine.

[13]  Menachem Elimelech,et al.  Antibacterial effects of carbon nanotubes: size does matter! , 2008, Langmuir : the ACS journal of surfaces and colloids.

[14]  Navneet Verma,et al.  Carbon Nanotubes: An Emerging Drug Carrier for Targeting Cancer Cells , 2014, Journal of drug delivery.

[15]  V. Théodorou,et al.  Mucus: An Underestimated Gut Target for Environmental Pollutants and Food Additives , 2018, Microorganisms.

[16]  A. Keshavarzian,et al.  Particulate matter air pollution causes oxidant-mediated increase in gut permeability in mice , 2011, Particle and Fibre Toxicology.

[17]  F. Bäckhed,et al.  Diet–microbiota interactions as moderators of human metabolism , 2016, Nature.

[18]  J. Borneman,et al.  Bacteria and bacterial rRNA genes associated with the development of colitis in IL‐10−/− Mice , 2008, Inflammatory bowel diseases.

[19]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[20]  M. Wang,et al.  The effects of orally administered Ag, TiO 2 and SiO 2 nanoparticles on gut microbiota composition and colitis induction in mice , 2017 .

[21]  S. Mody,et al.  Haemoglobin level and its clinical impact in a cohort of patients with COPD , 2007, European Respiratory Journal.

[22]  Aleksandar Milosavljevic,et al.  Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. , 2011, Gastroenterology.

[23]  Richard A. Flavell,et al.  NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis , 2011, Cell.

[24]  J. Pauluhn.  Multi-walled carbon nanotubes (Baytubes): approach for derivation of occupational exposure limit. , 2010, Regulatory toxicology and pharmacology : RTP.

[25]  Martin J. Blaser,et al.  Antibiotic use and its consequences for the normal microbiome , 2016, Science.

[26]  P. Bork,et al.  Enterotypes of the human gut microbiome , 2011, Nature.

[27]  Katherine H. Huang,et al.  Structure, Function and Diversity of the Healthy Human Microbiome , 2012, Nature.

[28]  D. Scheinberg,et al.  The effects of amine-modified single-walled carbon nanotubes on the mouse microbiota , 2018, International journal of nanomedicine.

[29]  Steven R. Tannenbaum,et al.  Arsenic Exposure Perturbs the Gut Microbiome and Its Metabolic Profile in Mice: An Integrated Metagenomics and Metabolomics Analysis , 2014, Environmental health perspectives.

[30]  J. Pairon,et al.  Titanium dioxide nanoparticles induce matrix metalloprotease 1 in human pulmonary fibroblasts partly via an interleukin-1β-dependent mechanism. , 2013, American journal of respiratory cell and molecular biology.

[31]  T. Ohteki,et al.  Commensal Gram-positive bacteria initiates colitis by inducing monocyte/macrophage mobilization , 2014, Mucosal Immunology.

[32]  Cristiana G O Dal'molin,et al.  Genomic characterization of the uncultured Bacteroidales family S24-7 inhabiting the guts of homeothermic animals , 2016, Microbiome.

[33]  Z. Chai,et al.  Broad-spectrum antibacterial activity of carbon nanotubes to human gut bacteria. , 2013, Small.

[34]  J. Nicholson,et al.  Host-Gut Microbiota Metabolic Interactions , 2012, Science.

[35]  Bing Wang,et al.  Graphene oxide as an anaerobic membrane scaffold for the enhancement of B. adolescentis proliferation and antagonistic effects against pathogens E. coli and S. aureus , 2014, Nanotechnology.

[36]  S. Biswal,et al.  Transport of metal oxide nanoparticles and single-walled carbon nanotubes in human mucus , 2012, Nanotoxicology.

[37]  R. Baughman,et al.  Carbon Nanotubes: Present and Future Commercial Applications , 2013, Science.